Valuation: Edwards Lifesciences Corporation

Market Cap 53.19B 45.63B 42.6B 39.09B 73.51B 5,084B 74.72B 503B 197B 2,550B 200B 195B 8,430B P/E 2026 *
36.5x
P/E 2027 * 27.9x
Enterprise Value 49.56B 42.51B 39.7B 36.42B 68.49B 4,737B 69.62B 468B 183B 2,376B 186B 182B 7,855B EV / Sales 2026 *
7.33x
EV / Sales 2027 * 6.46x
Free-Float
86.96%
Yield 2026 *
-
Yield 2027 * -
1 day+0.67%
1 week-0.83%
Current month+7.22%
1 month+7.64%
3 months+12.32%
6 months+16.93%
Current year+8.25%
1 week 90.4
Extreme 90.4
93.25
1 month 81.16
Extreme 81.155
93.91
Current year 74.66
Extreme 74.66
96.29
1 year 72.3
Extreme 72.3
96.29
3 years 58.93
Extreme 58.93
96.29
5 years 58.93
Extreme 58.93
131.73
10 years 27.04
Extreme 27.04
131.73
Manager TitleAgeSince
Chief Executive Officer 58 2023-05-10
Director of Finance/CFO 43 2026-05-28
Chief Tech/Sci/R&D Officer 51 2025-08-31
Director TitleAgeSince
Chairman 69 2024-05-06
Director/Board Member 62 2015-02-09
Director/Board Member 58 2023-05-10
Date Insider Type Main position Quantity % Market Cap.
8/11/26 Fiscal year

Executive/Senior Manager

1,857 0.0003%
7/30/26 Sell

Executive/Senior Manager

-146 0.0000%
7/28/26 Fiscal year

Executive/Senior Manager

28,884 0.0050%
Change 5-day change 1-year change 3-year change Capi.($)
+1.43%-0.83%+16.91%+20.50% 53.19B
+4.16%+1.75%+23.13%+15.24% 227B
+5.97%+2.77%-0.33%-15.87% 149B
+1.67%-0.88%-17.00%+39.09% 141B
+3.05%+1.15%-49.87%+3.63% 75.37B
-0.11%+2.33%-17.05%-12.16% 51.88B
+4.70%+4.84%+29.39%+30.32% 43.89B
+3.64%-0.07%+39.67%+54.01% 40.86B
+2.74%+3.24%+0.88%+9.16% 33.7B
+4.85%+2.06%-19.36%+39.22% 33.27B
Average +2.41%+1.44%+0.64%+18.31% 84.82B
Weighted average by Cap. +1.75%+1.34%+1.61%+14.71%

Financials

2026 *2027 *
Net sales 6.76B 5.8B 5.41B 4.97B 9.34B 646B 9.49B 63.89B 25.02B 324B 25.38B 24.83B 1,071B 7.43B 6.37B 5.95B 5.46B 10.27B 710B 10.44B 70.22B 27.5B 356B 27.89B 27.29B 1,177B
Net income 1.44B 1.23B 1.15B 1.05B 1.98B 137B 2.02B 13.56B 5.31B 68.8B 5.39B 5.27B 227B 1.9B 1.63B 1.52B 1.39B 2.62B 181B 2.66B 17.93B 7.02B 90.92B 7.12B 6.97B 301B
Net Debt -3.63B -3.11B -2.91B -2.67B -5.02B -347B -5.1B -34.32B -13.44B -174B -13.63B -13.34B -575B -5.19B -4.46B -4.16B -3.82B -7.18B -497B -7.3B -49.1B -19.23B -249B -19.5B -19.08B -823B
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (74%); - hemodynamic monitoring systems (9.1%); - other (16.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (25%), Japan (5.8%) and other (10.8%).
Employees
16,000
Date Price Change Volume
26-08-19 $92.28 +1.43% 3,406,151
26-08-18 $90.98 +0.19% 2,762,349
26-08-17 $90.81 -0.86% 2,246,351
26-08-14 $91.60 -1.04% 2,856,892
26-08-13 $92.56 -0.53% 2,809,926
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
92.28USD
Average target price
100.96USD
Spread / Average Target
+9.41%

Quarterly revenue - Rate of surprise